It can't be marketed, it doesn't make doctors wealthy like the helmet, it is only compassionate use and requires a large out of pocket, up front investment. So that narrative that it is already available and there is no market for it... is premature and not an accurate read for an approved drug, that can be marketed and where, and this is important, word has gotten out, because it still won't be possible to market it in other countries.
Approval will be a major game changer because it means it is likely approvable in these other markets however, and that should open up more opportunities for company collaboration with other potential partners, probably accelerate discussions on deals and make things a lot easier at least when they have a reasonable revenue stream. The UK is closer to Europe, but you don't see a lot of medical tourism to the UK historically. But could happen. Just not a common thing.
I do expect, if the UK approved and given previous German favorability, you could see an approval from the EMA as highly likely. I also think it will be highly influential on the FDA to accelerate their efforts to get this to market in the U.S.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
AI
